Peter Berghoefer - Rhoen Klinikum Member of the Supervisory Board
RKAGY Stock | USD 6.05 0.00 0.00% |
Executive
Mr. Peter Berghoefer is Member of the Supervisory Board, Employee Representative of RHOENKLINIKUM Aktiengesellschaft since June 9, 2010. Additionally, he acts as Member of Audit Committee of the Company. Furthermore, Mr. Berghoefer serves as Head of Finance at Universtaetsklinikum Giessen und Marburg GmbH, and since December 2015, he serves as Member of the Supervisory Board at Universtaetsklinikum Giessen und Marburg GmbH. since 2010.
Tenure | 14 years |
Phone | 49 9771 65 0 |
Web | https://www.rhoen-klinikum-ag.com |
Rhoen Klinikum Management Efficiency
The company has return on total asset (ROA) of 0.0114 % which means that it generated a profit of $0.0114 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0265 %, meaning that it generated $0.0265 on every $100 dollars invested by stockholders. Rhoen Klinikum's management efficiency ratios could be used to measure how well Rhoen Klinikum manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | EXECUTIVE Age | ||
Cheryl Levy | Encompass Health Corp | 58 | |
Mark Palmenter | Acadia Healthcare | N/A | |
Anderson Sr | National HealthCare | 62 | |
Bill Priest | Acadia Healthcare | N/A | |
Heather CPA | Acadia Healthcare | 52 | |
Henry Toledo | ModivCare | N/A | |
Kirk Cheney | Pennant Group | N/A | |
Shelly Eckenroth | Select Medical Holdings | N/A | |
Benjamin Adams | InnovAge Holding Corp | 60 | |
Cara Babachicos | InnovAge Holding Corp | N/A | |
Kenneth Shepard | ModivCare | 43 | |
Christine Bent | InnovAge Holding Corp | 53 | |
Laura Groschen | Acadia Healthcare | N/A | |
Bridget Sherick | Select Medical Holdings | N/A | |
Andrew Price | Encompass Health Corp | 57 | |
Mary Lacey | Select Medical Holdings | N/A | |
Matt Huray | InnovAge Holding Corp | N/A | |
Isa Diaz | Acadia Healthcare | N/A | |
Jing Zhang | Concord Medical Services | 49 | |
Mark Brewer | Enhabit | N/A | |
Nicole DAmato | InnovAge Holding Corp | 45 |
Management Performance
Return On Equity | 0.0265 | |||
Return On Asset | 0.0114 |
Rhoen Klinikum AG Leadership Team
Elected by the shareholders, the Rhoen Klinikum's board of directors comprises two types of representatives: Rhoen Klinikum inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Rhoen. The board's role is to monitor Rhoen Klinikum's management team and ensure that shareholders' interests are well served. Rhoen Klinikum's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Rhoen Klinikum's outside directors are responsible for providing unbiased perspectives on the board's policies.
Katrin Vernau, Member of the Supervisory Board | ||
Peter Berghoefer, Member of the Supervisory Board | ||
Tobias Kaltenbach, Chief Board | ||
Kai Klinger, Head of Investor Relations | ||
Stefan Stranz, CFO Board | ||
Klaus Hanschur, Member of the Supervisory Board | ||
JensPeter Neumann, Member of the Management Board, CFO | ||
Esther Walter, Head PR | ||
Brigitte Mohn, Member of the Supervisory Board | ||
Joachim Lueddecke, First Deputy Chairman of the Supervisory Board | ||
Bjoern Borgmann, Member of the Supervisory Board | ||
Meike Jaeger, Member of the Supervisory Board | ||
Gerhard Ehninger, Member of the Supervisory Board | ||
Pr Griewing, Chief Medical Officer and Member of Management Board | ||
Christine Reissner, Member of the Supervisory Board | ||
Annette Beller, Member of the Supervisory Board | ||
Martin Menger, COO and Member of the Management Board | ||
Oliver Salomon, Member of the Supervisory Board | ||
Eugen Mnch, Chief Representative | ||
Wolfgang Muendel, Second Deputy Chairman of the Supervisory Board | ||
Michael Mendel, Member of the Supervisory Board | ||
Reinhard Hartl, Member of the Supervisory Board | ||
Sylvia Buehler, Member of the Supervisory Board | ||
Jrg Demmler, Head Environment | ||
Bernd Griewing, Member of the Management Board, Chief Medical Officer | ||
FranzJosef Schmitz, Member of the Supervisory Board | ||
Bettina Boettcher, Member of the Supervisory Board | ||
Julian Schmitt, Head Treasury | ||
Stephan Holzinger, Member of the Supervisory Board | ||
Elke Pfeifer, Head Marketing | ||
Stefan Haertel, Member of the Supervisory Board | ||
Gunther Weiss, Member of the Management Board | ||
Heinz Korte, Member of the Supervisory Board | ||
Natascha Weihs, Member of the Supervisory Board | ||
Harald Auner, Patient Division | ||
Franz Mlynek, Divisional Investments | ||
Ludwig Braun, Member of the Supervisory Board | ||
Eugen Muench, Chairman of the Supervisory Board | ||
Gunther MSc, COO Board | ||
Martin Siebert, Chairman of Management Board and CEO | ||
Helmut Buehner, Member of the Supervisory Board | ||
Evelin Schiebel, Member of the Supervisory Board | ||
Georg SchulzeZiehaus, First Deputy Chairman of the Supervisory Board |
Rhoen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Rhoen Klinikum a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.0265 | |||
Return On Asset | 0.0114 | |||
Profit Margin | 0.02 % | |||
Operating Margin | 0.02 % | |||
Current Valuation | 928.19 M | |||
Shares Outstanding | 133.88 M | |||
Price To Earning | 540.83 X | |||
Price To Book | 0.68 X | |||
Price To Sales | 0.66 X | |||
Revenue | 1.4 B |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Rhoen Klinikum in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Rhoen Klinikum's short interest history, or implied volatility extrapolated from Rhoen Klinikum options trading.
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rhoen Klinikum AG. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Rhoen Klinikum AG information on this page should be used as a complementary analysis to other Rhoen Klinikum's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Complementary Tools for Rhoen Pink Sheet analysis
When running Rhoen Klinikum's price analysis, check to measure Rhoen Klinikum's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rhoen Klinikum is operating at the current time. Most of Rhoen Klinikum's value examination focuses on studying past and present price action to predict the probability of Rhoen Klinikum's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rhoen Klinikum's price. Additionally, you may evaluate how the addition of Rhoen Klinikum to your portfolios can decrease your overall portfolio volatility.
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Transaction History View history of all your transactions and understand their impact on performance | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |